Skip to main content
. Author manuscript; available in PMC: 2021 Jul 27.
Published in final edited form as: Neurosci Lett. 2020 May 1;732:135017. doi: 10.1016/j.neulet.2020.135017

Table 2. Statistical summary of survival curves for each varied PFF injection experiment.

All mPFF dosage experiments were compared to the 5 μg mPFFs cohort as the control. All comparisons for the PFFs containing C-truncated or phosphomimetic S129E αsyn were made with FL αsyn PFFs as the control. Shown are p-value summaries for survival curve comparisons using the log-rank test or Gehan-Breslow-Wilcoxon (GBW) test.

Comparison Log rank p value GBW test p value
Modified hPFFs
1-115 vs FL **** ****
1-119 vs FL **** ****
1-122 vs FL *** ***
1-125 vs FL ** **
1-129 vs FL **** ****
S129E vs FL (WT) * **
Mixed hPFFs
1-115/FL vs FL NS NS
1-119/FL vs FL ** **
1-122/FL vs FL * **
1-125/FL vs FL NS NS
1-129/FL vs FL NS NS
Dosage
10ug vs 5ug NS NS
2ug vs 5ug NS NS
1ug vs 5ug NS NS
0.5ug vs 5ug NS NS
0.1ug vs 5ug ** **
Sex
male vs female NS NS

NS = no significance,

*

= p ≤ 0.05,

**

= p ≤ 0.01,

***

= p ≤ 0.001,

****

= p ≤ 0.0001.